More broadly, our study highlights a critical facet of the tumor-TAM interaction: while proinflammatory cytokines IL-1β and TNF-α promote tumor progression, they also create a metabolic vulnerability in pancreatic cancer cells by enforcing reliance on the de novo pyrimidine synthesis pathway. The gene discussed is IL1B; the disease is neoplasm.